These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3098416)

  • 41. 5-S-cysteinyldopa and pigment response to UVA light.
    Tegner E; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(1):21-5. PubMed ID: 6191484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tyrosinase activity in the medium of human melanoma cell cultures.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(3):205-8. PubMed ID: 6192632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative determination of 5-S-cysteinyldopa, dopa and dopamine in the urine by means of high-performance liquid chromatography. A comparison with data obtained by means of fluorometry.
    Morishima T; Saito M; Hanawa S
    J Dermatol; 1981 Aug; 8(4):301-4. PubMed ID: 6795251
    [No Abstract]   [Full Text] [Related]  

  • 44. Studies on amelanotic melanoma with the fluorescence method (Falck and Hillarp) and biochemical analysis of 5-S-cysteinyldopa in the tissues.
    Morishima T; Tatsumi F; Fukada E; Watanabe M; Nagashima N; Hanawa S
    Arch Dermatol Res; 1983; 275(5):329-33. PubMed ID: 6419680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Melanocytic lesions of the genital area with attention given to atypical genital nevi.
    Ribé A
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():24-7. PubMed ID: 18976416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxidation of tyrosine residues in proteins by tyrosinase. Formation of protein-bonded 3,4-dihydroxyphenylalanine and 5-S-cysteinyl-3,4-dihydroxyphenylalanine.
    Ito S; Kato T; Shinpo K; Fujita K
    Biochem J; 1984 Sep; 222(2):407-11. PubMed ID: 6433900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diagnosis of amelanotic malignant melanoma by means of the fluorescence method (Falck & Hillarp) and determination of 5-S-cysteinyldopa in the lesions].
    Morishima T; Fukada E; Nagashima N
    Nihon Hifuka Gakkai Zasshi; 1983 Jan; 93(1):51-4. PubMed ID: 6408288
    [No Abstract]   [Full Text] [Related]  

  • 48. Detection of p53 mutations in benign and dysplastic nevi.
    Levin DB; Wilson K; Valadares de Amorim G; Webber J; Kenny P; Kusser W
    Cancer Res; 1995 Oct; 55(19):4278-82. PubMed ID: 7671235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. De novo intraepidermal epithelioid melanocytic dysplasia as a marker of the atypical mole phenotype -- a clinical and pathological study of 75 patients.
    Sachdeva M; Frambach GE; Crowson AN; Deng AC; Mihm MC; Magro CM
    J Cutan Pathol; 2005 Oct; 32(9):622-8. PubMed ID: 16176300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Borderline and atypical melanocytic lesions.
    Brodell RT; Santa Cruz DJ
    Semin Diagn Pathol; 1985 Feb; 2(1):63-86. PubMed ID: 3916688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of intracellular pigments on emission spectra of biogenic amines. Microfluorimetric study on pigment synthesizing cells in human skin].
    Paul E; Hartwig HG
    Verh Anat Ges; 1976; (70 Pt 1):479-81. PubMed ID: 1023601
    [No Abstract]   [Full Text] [Related]  

  • 52. Natural history of melanocytic nevi.
    Brodell R; Sims DM; Zaim MT
    Am Fam Physician; 1988 Nov; 38(5):93-101. PubMed ID: 3189133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acquired unilateral melanocytic nevi in otherwise normal skin.
    Yu X; Nagai H; Nishigori C; Horikawa T
    Dermatology; 2008; 217(1):63-5. PubMed ID: 18401177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nodal melanocytic nevus with balloon-cell change (nodal balloon-cell nevus).
    Urso C
    J Cutan Pathol; 2008 Jul; 35(7):672-6. PubMed ID: 18312441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Melanocytic nevi and malignant melanoma.
    Metcalf JS; Maize JC
    Dermatol Clin; 1985 Apr; 3(2):217-24. PubMed ID: 3830485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formation of cysteine conjugates from dihydroxyphenylalanine and its S-cysteinyl derivatives by peroxidase-catalyzed oxidation.
    Ito S; Fujita K
    Biochim Biophys Acta; 1981 Jan; 672(2):151-7. PubMed ID: 6784771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR; Zhu W; Thomas D; Su LD
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Intra-epithelial melanocytic neoplasia (MIN), a new term proposed for dysplastic melanocytic lesions].
    Collina G
    Pathologica; 1997 Apr; 89(2):196-8. PubMed ID: 9411373
    [No Abstract]   [Full Text] [Related]  

  • 59. Sclerosing nevus with pseudomelanomatous features.
    Fabrizi G; Pennacchia I; Pagliarello C; Massi G
    J Cutan Pathol; 2008 Nov; 35(11):995-1002. PubMed ID: 18537860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The clinical appearance of clonal nevi (inverted type A nevi).
    Huynh PM; Glusac EJ; Bolognia JL
    Int J Dermatol; 2004 Dec; 43(12):882-5. PubMed ID: 15569007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.